191 results
S-8
EX-99.4
ITCI
Intra-Cellular Therapies Inc
25 Jun 24
Registration of securities for employees
4:28pm
Regulation T as promulgated by the Federal Reserve Board), any sums required to satisfy the federal, state, local and foreign tax withholding obligations … , determined by the Company as of the date of exercise, not in excess of the maximum amount of tax required to be withheld by law (or such other amount
S-8
EX-99.7
ITCI
Intra-Cellular Therapies Inc
25 Jun 24
Registration of securities for employees
4:28pm
to satisfaction of the tax withholding obligations set forth in Section 9 and (ii) intended to comply with Treasury Regulations Section 1.409A-1(b)(4 … for “good reason” or for a “constructive termination” (or similar term) under any agreement with the Company.
9. Tax Liability of the Participant
S-8
EX-99.3
ITCI
Intra-Cellular Therapies Inc
25 Jun 24
Registration of securities for employees
4:28pm
and foreign tax withholding obligations of the Company or an Affiliate, if any, which arise in connection with the exercise of your option.
(b) Upon … of Common Stock having a Fair Market Value, determined by the Company as of the date of exercise, not in excess of the maximum amount of tax required
S-8
EX-99.5
ITCI
Intra-Cellular Therapies Inc
25 Jun 24
Registration of securities for employees
4:28pm
shares of Common Stock in respect of this Award is (i) subject to satisfaction of the tax withholding obligations set forth in Section 9 and (ii … . Tax Liability of the Participant and Payment of Taxes. The Participant acknowledges and agrees that any income or other taxes due from
S-8
EX-99.6
ITCI
Intra-Cellular Therapies Inc
25 Jun 24
Registration of securities for employees
4:28pm
is (i) subject to satisfaction of the tax withholding obligations set forth in Section 9 and (ii) intended to comply with Treasury Regulations Section … Director Form – Electronic Version
9. Tax Liability of the Participant and Payment of Taxes. The Participant acknowledges and agrees that any income
S-8
EX-99.2
ua7gjz44993pjhsg
25 Jun 24
Registration of securities for employees
4:28pm
8-K
EX-10.1
x0kfl8jwtxnss6rkbjj
18 Jun 24
Departure of Directors or Certain Officers
4:16pm
8-K
EX-99.1
eqxqz61
7 May 24
Intra-cellular Therapies Reports First Quarter 2024 Financial Results
7:40am
8-K
EX-1.1
fy2k0en4
18 Apr 24
Entry into a Material Definitive Agreement
5:25pm
424B5
knhjfdh sbayoh5einri
18 Apr 24
Prospectus supplement for primary offering
5:23pm
424B5
iuuq3lf
16 Apr 24
Prospectus supplement for primary offering
4:37pm
S-3ASR
EX-4.11
5qij6
16 Apr 24
Automatic shelf registration
4:01pm
S-3ASR
4n16633m3knbcey7mi
16 Apr 24
Automatic shelf registration
4:01pm
S-3ASR
EX-4.10
rmgugqi2 xl11hjc7
16 Apr 24
Automatic shelf registration
4:01pm
8-K
EX-99.1
pqh72vo4jb
22 Feb 24
Intra-cellular Therapies Reports Fourth Quarter and Full-year 2023 Financial Results and Provides Corporate Update
7:39am